Generic drug industry to flourish, analyst says

09/6/2007 | Boston Globe (tiered subscription model), The

Generic drug makers will continue reaping bigger profits, as the annual sales growth rate of 14% for generic drugs is far above that of the single-digit annual growth rate of brand-name drugmakers, top industry analyst Doug Long predicts. However, Long warns that price competition and "innovation slowdown" will affect the growth of generic drug makers.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA